Clearside Biomedical (CLSD) Price & Analysis

Q: What was Clearside Biomedical’s price range in the past 12 months?

Clearside Biomedical lowest stock price was $3.32 and its highest was $17.40 in the past 12 months.

Q: What is Clearside Biomedical’s market cap?

Clearside Biomedical’s market cap is $19.37M.

Q: When is Clearside Biomedical’s upcoming earnings report date?

Clearside Biomedical’s upcoming earnings report date is Nov 18, 2025 which is in 6 days.

Q: How were Clearside Biomedical’s earnings last quarter?

Clearside Biomedical released its earnings results on Aug 18, 2025. The company reported -$1.5 earnings per share for the quarter, missing the consensus estimate of -$1.371 by -$0.129.

Q: Is Clearside Biomedical overvalued?

According to Wall Street analysts Clearside Biomedical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Clearside Biomedical pay dividends?

Clearside Biomedical does not currently pay dividends.

Q: What is Clearside Biomedical’s EPS estimate?

Clearside Biomedical’s EPS estimate is -0.75.

Q: How many shares outstanding does Clearside Biomedical have?

Clearside Biomedical has 5,234,021 shares outstanding.

Q: What happened to Clearside Biomedical’s price movement after its last earnings report?

Clearside Biomedical reported an EPS of -$1.5 in its last earnings report, missing expectations of -$1.371. Following the earnings report the stock price went up 0.789%.

Q: Which hedge fund is a major shareholder of Clearside Biomedical?

Currently, no hedge funds are holding shares in CLSD

Compare

1,078 Followers

CLSD Stock Chart & Stats

$3.68

<$0.01(0.46%)

At close: Jan 08 4:00 PM EST

$3.68

<$0.01(0.46%)

Day’s Range― - ―

52-Week Range$3.32 - $17.40

Previous CloseN/A

Volume106.43K

Average Volume (3M)64.39K

Market Cap

$19.37M

Enterprise Value$109.13M

Total Cash (Recent Filing)$9.38M

Total Debt (Recent Filing)$533.00K

Price to Earnings (P/E)―

Beta1.08

Next Earnings

Nov 18, 2025

EPS Estimate

-0.75

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1.50

Shares Outstanding5,234,021

10 Day Avg. Volume36,098

30 Day Avg. Volume64,393

Financial Highlights & Ratios

PEG Ratio0.18

Price to Book (P/B)-1.80

Price to Sales (P/S)42.14

P/FCF Ratio-2.73

Enterprise Value/Market Cap5.64

Enterprise Value/Revenue26.20

Enterprise Value/Gross Profit29.62

Enterprise Value/Ebitda-6.74

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusHold

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Strategic Alternatives ExplorationCLSD announced plans to explore a full range of strategic alternatives with an investment bank to advance its CLS-AX program and maximize shareholder value.

Bears Say

Financial ConstraintsCLSD's last reported cash balance is expected to fund operations only for a limited time, indicating financial constraints.

Funding ChallengesCLSD is facing difficulties in securing funding or partnerships to advance its CLS-AX program into phase 3 development.

Internal RestructuringCLSD has paused all internal R&D programs and remaining employees, including key executives, are transitioning into consultant roles to conserve cash.

Clearside Biomedical News

VTI ETF Daily Report: 11/10/2025

The Vanguard Total Stock Market ETF ($VTI) tracks the performance of the entire U.S. equity market. VTI ETF is...

2d ago

LVO

VTI

VTI ETF Daily Update: What Investors Need to Know – 11/6/2025

How is the VTI ETF faring? Vanguard Total Stock Market ETF ($VTI) is an all-in-one fund that lets...

6d ago

LVO

VTI

VTI ETF Daily Update: What Investors Need to Know – 11/5/2025

How is the VTI ETF faring? Vanguard Total Stock Market ETF ($VTI) is an all-in-one fund that lets...

7d ago

LVO

VTI

VTI ETF Daily Update, 10/27/2025

How is VTI ETF faring? Vanguard Total Stock Market ETF ($VTI) is an all-in-one fund that lets investors...

16d ago

LVO

VTI

VTI ETF Daily Update, 10/24/2025

How is VTI ETF faring? Vanguard Total Stock Market ETF ($VTI) is an all-in-one fund that lets investors...

19d ago

IBM

LVO

VTI ETF Daily Update, 10/23/2025

How is VTI stock faring? Vanguard Total Stock Market ETF ($VTI) is an all-in-one fund that lets investors...

20d ago

LVO

TXN

Clearside Biomedical Regains Nasdaq Compliance as of October 2025

Clearside Biomedical ( ($CLSD) ) has shared an announcement. Clearside Biomedical, Inc. has successfully regained compliance with Nasdaq’s...

1M ago

CLSD

Upcoming Stock Splits This Week (September 15 to September 19) – Stay Invested

These are the upcoming stock splits for the week of September 15 to September 19, based on TipRanks’ Stock...

2M ago

REX

ATHA

Clearside Biomedical trading halted, news pending

19:50 EDT Clearside Biomedical (CLSD) trading halted, news pending Published first on TheFly – the ultimate source for...

2M ago

CLSD

Clearside Biomedical Announces Reverse Stock Split Plan

The latest update is out from Clearside Biomedical ( ($CLSD) ). On September 10, 2025, Clearside Biomedical, Inc....

2M ago

CLSD

Clearside Biomedical Announces Reverse Stock Split

An update from Clearside Biomedical ( ($CLSD) ) is now available. On September 10, 2025, Clearside Biomedical, Inc....

2M ago

CLSD

Clearside Biomedical announces approval of XIPERE in Canada

Clearside Biomedical (CLSD) announced that Health Canada has granted approval for XIPERE for suprachoroidal use in the treatment...

4M ago

CLSD

Snowflake initiated, Chipotle upgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

4M ago

ABT

Clearside Biomedical downgraded to Neutral from Buy at H.C. Wainwright

H.C. Wainwright downgraded Clearside Biomedical (CLSD) to Neutral from Buy without a price target after the company said...

4M ago

CLSD

CLSD FAQ

What was Clearside Biomedical’s price range in the past 12 months?

Clearside Biomedical lowest stock price was $3.32 and its highest was $17.40 in the past 12 months.

What is Clearside Biomedical’s market cap?

Clearside Biomedical’s market cap is $19.37M.

When is Clearside Biomedical’s upcoming earnings report date?

Clearside Biomedical’s upcoming earnings report date is Nov 18, 2025 which is in 6 days.

How were Clearside Biomedical’s earnings last quarter?

Clearside Biomedical released its earnings results on Aug 18, 2025. The company reported -$1.5 earnings per share for the quarter, missing the consensus estimate of -$1.371 by -$0.129.

Is Clearside Biomedical overvalued?

According to Wall Street analysts Clearside Biomedical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Clearside Biomedical pay dividends?

Clearside Biomedical does not currently pay dividends.

What is Clearside Biomedical’s EPS estimate?

Clearside Biomedical’s EPS estimate is -0.75.

How many shares outstanding does Clearside Biomedical have?

Clearside Biomedical has 5,234,021 shares outstanding.

What happened to Clearside Biomedical’s price movement after its last earnings report?

Clearside Biomedical reported an EPS of -$1.5 in its last earnings report, missing expectations of -$1.371. Following the earnings report the stock price went up 0.789%.

Which hedge fund is a major shareholder of Clearside Biomedical?

Currently, no hedge funds are holding shares in CLSD

Company Description

Clearside Biomedical

Clearside Biomedical, Inc. is a biopharmaceutical company focused on developing innovative therapies for treating serious eye diseases. The company operates primarily in the ocular therapeutics sector, leveraging its proprietary drug delivery platform, the SCS Microinjector, to enhance the delivery of therapeutics directly to the suprachoroidal space of the eye. Clearside's core products include its lead asset, Xipere (triamcinolone acetonide injectable suspension), approved for the treatment of macular edema associated with uveitis, as well as a pipeline of product candidates aimed at various ocular conditions.